: Explained: Why it took nearly 30 years to develop a vaccine for malaria #IndiaNEWS On October 6, the World Health Organization approved the first vaccine against malaria after a nearly seven-decade

Explained: Why it took nearly 30 years to develop a vaccine for malaria #IndiaNEWS
On October 6, the World Health Organization approved the first vaccine against malaria after a nearly seven-decade global battle against the disease that claims more than 4 lakh lives each year. The WHO has recommended a widespread deployment of the vaccine – RTS,S/AS01 that is developed by GlaxoSmithKline for children below five years in sub-Saharan Africa and other at-risk regions.“This is a historic moment,??? said WHO Director-General Dr Tedros Adhanom Ghebreyesus.??? The long-awaited malaria vaccine for children is a breakthrough for science, child health and malaria control.??? “Using this vaccine on top of existing tools to prevent malaria could save tens of thousands of young lives each year,??? he said.However, it is to be noted that RTS,S is a vaccine that acts only against one species of the Plasmodium parasite known as the Plasmodium falciparum (the deadliest malaria parasite globally and the most prevalent one in Africa). The vaccine offers no protection against the other four species such as P vivax, P ovale, P knowlesi and P malariae which are prevalent in Southeast Asia, Americas and Europe.According to WHO’s World Malaria Report 2020, the WHO African region accounted for 94% of malaria cases in 2019 carrying the highest share of the global malaria burden. In 2018, the species P falciparum accounted for 99.7% of estimated malaria cases in the WHO African Region,...Read more

Stock Market NEWS Best intraday tips Intraday Stocks below 100